This Publicly Available Specification lists terms and definitions:
a) associated with the naming of types of regenerative medicine
products and therapies;
b) that describe materials, processes, methodologies and applications
within regenerative medicine.
It covers:
i) general terms (see Clause 2);
ii) cell and tissue components (Clause 3)
iii) non-cellular components (see Clause 4);
iv) cell and tissue procurement (see Clause 5);
v) measurement and analysis (see Clause 6);
vi) manufacturing and production (see Clause 7);
vii) clinical trials (see Clause 8 and Table A.1);
viii) regulatory terms for products and therapies (see Table A.2).